Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells
- 30 June 2004
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 221 (1-2) , 67-74
- https://doi.org/10.1016/j.mce.2004.03.003
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High‐dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinomaCancer, 2003
- New insights into the mechanisms of vitamin D actionJournal of Cellular Biochemistry, 2003
- Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expressionJournal of Cellular Biochemistry, 2003
- Prostatic 25‐hydroxyvitamin D‐1α‐hydroxylase and its implication in prostate cancerJournal of Cellular Biochemistry, 2003
- The Mechanism of 1,25-Dihydroxyvitamin D3Autoregulation in KeratinocytesJournal of Biological Chemistry, 2002
- Going malignant: the hypoxia‐cancer connection in the prostateBioEssays, 2002
- 25-Hydroxyvitamin D3-1 -Hydroxylase Expression in Normal and Pathological Parathyroid GlandsJournal of Clinical Endocrinology & Metabolism, 2002
- 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- 25-Hydroxy-Vitamin D Metabolism in Human Colon Cancer Cells during Tumor ProgressionBiochemical and Biophysical Research Communications, 2001
- Vitamin D and Prostate CancerProceedings of the Society for Experimental Biology and Medicine, 1999